Participants with ≥ 1 adverse event following a single dose · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Median (mean) time to use of rescue medication · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Participants with a serious adverse event following a single dose · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Number of women requiring rescue medication · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Participants with ≥ 1 adverse event following a single dose · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Participants with a serious adverse event following a single dose · adults with moderate or severe acute postoperative pain
1 finding from 1 review
At least 50% of maximum pain relief over 4 to 6 hours · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Median (mean) time to use of rescue medication · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Number of women requiring rescue medication · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Participants with ≥ 1 adverse event following a single dose · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Substantial benefit · adults with postherpetic neuralgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
PGICvery much improved, week 8 and week 12 · adults with postherpetic neuralgia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Moderate benefit · adults with postherpetic neuralgia
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Patient Global Impression of Change much or very much improved · adults with postherpetic neuralgia
2 findings from 1 review
Lack of efficacy withdrawal · adults with postherpetic neuralgia
1 finding from 1 review
Withdrawals due to adverse events · adults with postherpetic neuralgia
1 finding from 1 review
Serious adverse events · adults with postherpetic neuralgia
1 finding from 1 review
Death · adults with postherpetic neuralgia
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · adults with postherpetic neuralgia
1 finding from 1 review
Withdrawals due to adverse events · adults with neuropathic pain
1 finding from 1 review